Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-12

FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved GLATOPA, a generic glatiramer acetate product by Sandoz, via a supplemental application to an approved ANDA for use in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATOPA (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATOPA (GLATIRAMER ACETATE)